Chemotherapy in the management of periosteal osteosarcoma: A narrative review

被引：14

作者：

Assi, Tarek ^{[1
]}

Kattan, Joseph ^{[2
]}

Nassereddine, Hussein ^{[3
]}

Rassy, Elie ^{[4
]}

Briand, Sylvain ^{[5
]}

Court, Charles ^{[5
]}

Verret, Benjamin ^{[4
]}

Le Cesne, Axel ^{[1
]}

Mir, Olivier ^{[6
]}

机构：

[1] Gustave Roussy, Div Int Patients Care, Sarcoma Grp, 114 Rue Edouard Vaillant, F-94805 Villejuif, France

[2] St Joseph Univ, Dept Hematol Oncol, Fac Med, Beirut, Lebanon

[3] St Joseph Univ, Dept Pathol, Hotel Dieu France, Fac Med, Beirut, Lebanon

[4] Gustave Roussy, Div Med Oncol, Sarcoma Grp, Villejuif, France

[5] Univ Paris Saclay, Bicetre Teaching Hosp, AP HP, Dept Orthopaed Surg, Le Kremlin Bicetre, France

[6] Gustave Roussy, Dept Ambulatory Canc Care, Sarcoma Grp, Villejuif, France

来源：

JOURNAL OF BONE ONCOLOGY | 2021年 / 30卷

关键词：

Osteosarcoma; Periosteal osteosarcoma; Chemotherapy; Sarcoma; Bone tumors; HIGH-GRADE OSTEOSARCOMA; NONMETASTATIC OSTEOSARCOMA; SARCOMA; TRIAL; CHONDROSARCOMA; METHOTREXATE; DOXORUBICIN; IFOSFAMIDE; EXTREMITY; SURVIVAL;

D O I：

10.1016/j.jbo.2021.100389

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Periosteal osteosarcoma (PO), an intermediate-grade chondroblastic osteosarcoma (OST) arising from the surface of the bones, is a rare histological subtype among primary bone sarcomas, most commonly diagnosed in young patients. It is characterized by distinct specific radiological and pathological features. The current management strategy is based on several case reports and series, without any solid international recommendations. Most sarcoma experts agree on the crucial role of an optimal complete surgical approach. However, with the paucity of available reports, the role of systemic treatment and its timing remains debatable. With this paper, we will review the available data on the actual impact of chemotherapy in PO patients with emphasis on the radiological, pathological, and therapeutic characteristics of this rare entity. (c) 2021 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页数：7

共 66 条

[1]

Barakat M. J., 2003, Sarcoma, V7, P79, DOI 10.1080/13577140310001607310

[2] PERIOSTEAL CHONDROSARCOMA AND PERIOSTEAL OSTEO-SARCOMA - 2 DISTINCT ENTITIES [J].

BERTONI, F ;

BORIANI, S ;

LAUS, M ;

CAMPANACCI, M .

JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1982, 64 (03) :370-376

[3] Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].

Bielack, SS ;

Kempf-Bielack, B ;

Delling, G ;

Exner, GU ;

Flege, S ;

Helmke, K ;

Kotz, R ;

Salzer-Kuntschik, M ;

Werner, M ;

Winkelmann, W ;

Zoubek, A ;

Jürgens, H ;

Winkler, K .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790

[4]

CAMPANACCI M, 1976, Italian Journal of Orthopaedics and Traumatology, V2, P23

[5]

Campanacci M., 1999, BONE SOFT TISSUE TUM

[6] Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].

Casali, P. G. ;

Bielack, S. ;

Abecassis, N. ;

Aro, H. T. ;

Bauer, S. ;

Biagini, R. ;

Bonvalot, S. ;

Boukovinas, I. ;

Bovee, J. V. M. G. ;

Brennan, B. ;

Brodowicz, T. ;

Martin-Broto, J. ;

Brugieres, L. ;

Buonadonna, A. ;

De Alava, E. ;

Dei Tos, A. P. ;

Del Muro, X. G. ;

Dileo, P. ;

Dhooge, C. ;

Eriksson, M. ;

Fagioli, F. ;

Fedenko, A. ;

Ferraresi, V. ;

Ferrari, A. ;

Ferrari, S. ;

Frezza, A. M. ;

Gaspar, N. ;

Gasperoni, S. ;

Gelderblom, H. ;

Gil, T. ;

Grignani, G. ;

Gronchi, A. ;

Haas, R. L. ;

Hassan, B. ;

Hecker-Nolting, S. ;

Hohenberger, P. ;

Issels, R. ;

Joensuu, H. ;

Jones, R. L. ;

Judson, I. ;

Jutte, P. ;

Kaal, S. ;

Kager, L. ;

Kasper, B. ;

Kopeckova, K. ;

Krakorova, D. A. ;

Ladenstein, R. ;

Le Cesne, A. ;

Lugowska, I. ;

Merimsky, O. .

ANNALS OF ONCOLOGY, 2018, 29 :79-95

[7] Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper [J].

Casali, P. G. ;

Bruzzi, P. ;

Bogaerts, J. ;

Blay, J. -Y. .

ANNALS OF ONCOLOGY, 2015, 26 (02) :300-306

[8] Periosteal Osteosarcoma A Single-Institution Experience [J].

Cesari, Marilena ;

Alberghini, Marco ;

Vanel, Daniel ;

Palmerini, Emanuela ;

Staals, Eric L. ;

Longhi, Alessandra ;

Abate, Massimo ;

Ferrari, Cristina ;

Balladelli, Alba ;

Ferrari, Stefano .

CANCER, 2011, 117 (08) :1731-1735

[9]

Chan Chung Ming, 2018, Sarcoma, V2018, P8631237, DOI 10.1155/2018/8631237

[10] PERIOSTEAL OSTEOSARCOMA AND PAROSTEAL CHONDROSARCOMA EVALUATED BY DOUBLE IMMUNOHISTOCHEMICAL STAINING - REPORT OF 2 CASES [J].

CHANO, T ;

MATSUMOTO, K ;

ISHIZAWA, M ;

MORIMOTO, S ;

HUKUDA, S ;

OKABE, H .

ACTA ORTHOPAEDICA SCANDINAVICA, 1994, 65 (03) :355-358

← 1 2 3 4 5 6 7 →